Virion Therapeutics

Developing T cell immunotherapies for cancer and chronic infectious diseases

placeNewark, Delaware, United States calendar_todayFounded 2018 groups7 employees language viriontx.com

Innovation

2 patent families (1 granted) — focus: Human necessities; filing pace accelerating. Cited 58 times.

YearFilings
20211
20221
20231
20242
20252

Social engagement

Social engagement: 929 social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record.

Investor typeCountShare
Venture capital229%
Angel & family office571%

Recent activity

29 May 2026
Product launch
VRON-0200 for Chronic HBV
24 Apr 2026
Event
APASL
Coming soon